Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Correspondence

Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study

Free

Online download statistics by month:

Online download statistics by month: January 2021 to February 2023

	Abstract	Full	Pdf
Jan 2021	449	444	134
Feb 2021	258	254	42
Mar 2021	79	76	32
Apr 2021	36	30	11
May 2021	63	67	9
Jun 2021	39	47	12
Jul 2021	32	41	7
Aug 2021	39	49	15
Sep 2021	28	37	22
Oct 2021	37	46	22
Nov 2021	38	47	22
Dec 2021	111	124	9
Jan 2022	56	65	7
Feb 2022	36	43	7
Mar 2022	41	52	2
Apr 2022	28	35	1
May 2022	40	47	12
Jun 2022	31	33	6
Jul 2022	32	39	5
Aug 2022	34	42	3
Sep 2022	27	38	9
Oct 2022	31	31	9
Nov 2022	25	26	1
Dec 2022	32	33	1
Jan 2023	41	41	10
Feb 2023	34	34	4
Total	1697	1821	414